Jane Street
XERS icon

Jane Street’s Xeris Biopharma Holdings XERS Stock Holding History

Jane Street’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Buy
+18,500
New +$123K ﹤0.01% 10611
2022
Q2 		– Sell
-10,300
Closed -$26K – 11062
2022
Q1 		$26K Sell
10,300
-12,800
-55% -$31.3K ﹤0.01% 9875
2021
Q4 		$68K Buy
+23,100
New +$49.9K ﹤0.01% 9409
2021
Q3 		– Sell
-45,900
Closed -$187K – 10851
2021
Q2 		$187K Buy
+45,900
New +$175K ﹤0.01% 8883

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's XERS Position: Q1 2026 in Review

Jane Street increased its Xeris Biopharma Holdings (XERS) stake by 308% in Q1 2026, buying an estimated $3.63M and bringing the position to 725,616 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3758.

Jane Street first reported a position in XERS in Q4 2020 and has held it in 22 quarters since. The position peaked at $7.44M in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Jane Street held 725,616 shares of Xeris Biopharma Holdings worth $4.21M as of Q1 2026.
  • Jane Street bought 547,794 Xeris Biopharma Holdings shares in Q1 2026, an estimated $3.63M.
  • Xeris Biopharma Holdings made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3758 holding.
  • Jane Street first reported a position in Xeris Biopharma Holdings in Q4 2020 and has held it in 22 quarters since.
  • Jane Street's Xeris Biopharma Holdings position peaked at $7.44M in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.